Watch this interactive, on-demand Webcast led by George D. Demetri, MD, and featuring an expert panel discussing best practices in testing for NTRK fusions in solid tumors, current evidence supporting the use of approved TRK inhibitors, and emerging topics, including TRK inhibitor resistance and second-generation agents.
Listen to George D. Demetri, MD; Alexander Drilon, MD; and Pashtoon Kasi, MD, answer audience questions from a series of live CCO Webinars focused on when and how to test for NTRK fusions in solid tumors and best practices in using TRK inhibitors.
Download this slideset for expert perspectives on current best practices in testing for NTRK fusions in solid tumors.
Download this slideset for expert perspectives on current best practices in the use of approved TRK inhibitors for patients with solid tumors.
Download this slideset for expert perspectives on emerging next-generation TRK inhibitors and their potential use in managing resistance to first-generation agents, as well key adverse events with TRK inhibitors and management strategies.
Read my thoughts on how I approach TRK inhibitor therapy, including testing for NTRK fusions and monitoring for adverse events.
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.